PIB TrackerTightening the tap: high-alcohol medicinal tinctures lose their licensing exemption under Drugs Rules
The Health Ministry amended the Drugs Rules, 1945 to remove the Schedule K licensing exemption for formulations with over 12% alcohol in packs above 30 ml — some tinctures run 80–90% alcohol — moving them to prescription-only Schedule H1 to curb diversion for intoxication.
What happened
- The Health Ministry amended the Drugs Rules, 1945 to strengthen oversight of high-alcohol medicinal formulations.
- Formulations with more than 12% v/v ethyl alcohol in packs above 30 mL lose the Schedule K licensing exemption.
- Some tinctures (cardamom, ginger, aromatic preparations) contain up to 80–90% alcohol and are misused for intoxication.
- Such products must now obtain licences under the Drugs and Cosmetics Act, 1940 and shift to Schedule H1 — prescription-only with stricter record-keeping.
- The change routes them through the regulated pharma supply chain, curbing diversion while keeping them available for legitimate therapeutic use.
For Prelims
- Drugs and Cosmetics Act, 1940 & Rules, 1945: The core law/rules regulating the import, manufacture and sale of drugs and cosmetics in India.
- Schedule K: Lists drugs exempted (fully or partly) from certain licensing provisions — the exemption now withdrawn for high-alcohol formulations.
- Schedule H1: Lists drugs that can be sold only against a prescription, with the seller keeping a register — created to curb antibiotic and habit-forming-drug misuse.
- CDSCO/DCGI: The Central Drugs Standard Control Organisation and the Drugs Controller General of India — the central drug regulator.
- Tincture: A medicine dissolved in alcohol; high-alcohol tinctures can be diverted as a cheap intoxicant, the misuse this targets.
- v/v: 'volume by volume' — the alcohol percentage by volume in a formulation.
For UPSC: Frame this as public-health regulation closing a loophole — reclassifying high-alcohol 'medicines' from exempt (Schedule K) to prescription-only (Schedule H1) to stop diversion for intoxication. Anchor the Drugs and Cosmetics Act framework, CDSCO/DCGI, the schedule system, and the balance between access to legitimate therapy and curbing substance abuse.
What it is NOT: This is a targeted regulatory tightening (removing an exemption and adding prescription control), not a ban or a new law — the products remain available for legitimate medical use. It applies to specific high-alcohol formulations above thresholds, not all medicinal tinctures.
For Mains
Syllabus: GS2.13 · GS2.9 · Linkage L1
Anchor
Closing regulatory loopholes in public health — reclassifying misuse-prone high-alcohol 'medicines' into the controlled prescription channel.
Substantiation (data)
Drugs Rules 1945 amendment: formulations over 12% v/v alcohol in packs above 30 mL lose the Schedule K exemption and move to prescription-only Schedule H1; some tinctures run 80–90% alcohol; states flagged misuse.
Exemplification
Cardamom/ginger tinctures diverted as cheap intoxicants; Schedule H1 prescription control and licensing as the fix within the Drugs and Cosmetics framework.
Problematisation
Enforcement at the retail level, availability of substitutes, and balancing genuine therapeutic access with abuse control remain challenges.
Way-forward
Enforce Schedule H1 record-keeping, monitor diversion, and pair with demand-reduction (de-addiction) and state coordination.
Position
Government stance: rational, responsible use of medicines with tighter regulation to safeguard public health.
Deploys into: Issues relating to health and the regulation of drugs (GS2.13) · statutory and regulatory bodies (GS2.9 — CDSCO/DCGI, Drugs & Cosmetics Act) · the schedule system (K vs H1), substance-abuse prevention and public-health regulation.
Ministry of Health & Family Welfare · 2026-07-10 · PRID 2283196 · PIB source ↗